[1]
|
Brownlee, M. (2005) Pathobiology of diabetic complications: A unifying mechanism. Diabetes; 54, 1615-1625.
doi:10.2337/diabetes.54.6.1615
|
[2]
|
Giugliano, D., Ceriello, A. and Paolisso, G. (1996) Oxidative stress and diabetic vascular complications. Diabetes Care; 19, 257-267. doi:10.2337/diacare.19.3.257
|
[3]
|
Mandal, A.K., Ping, T., Caldwell, S.J., Bagnell, R. and Hiebert, L.M. (2006)Electron microscopic analysis of glucose-induced endothelial damage in primary cell culture: possible mechanism and prevention. Histology and Histopathology, 21, 941-950.
|
[4]
|
Hiebert, L.M. and Liu, J. (1990) Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites. Atherosclerosis, 83, 47-51.
doi:10.1016/0021-9150(90)90129-7
|
[5]
|
Yokokawa, K., Mandal, A.K., Kohno, M., Horio, T., Murakawa, K., Yasunari, K. and Takeda, T (1992) Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rat. American Journal of Physiology, 263, R1035-R1041.
|
[6]
|
Mandal, A.K., Puchalski, J.T., Lemley-Gillespie, S., Taylor, C.A. and Kohno, M. (2000) Effect of insulin and heparin on glucose-induced vascular damage in cell culture. Kidney International, 57, 2492-2501.
doi:10.1046/j.1523-1755.2000.00108.x
|
[7]
|
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Research and Clinical Practice, 28, 103- 117. doi:10.1016/0168-8227(95)01064-K
|
[8]
|
Reichard, P., Nilsson, R.Y. and Rosenqvist, U. (1993) The effect of long-term insulin treatment on the development of microvascular complications of diabetes mellitus. The New England Journal of Medicine, 329, 304- 309. doi:10.1056/NEJM199307293290502
|
[9]
|
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. The New England Journal of Medicine, 329, 977-986.
doi:10.1056/NEJM199309303291401
|
[10]
|
Fabre, J., Balant, L.P., Dayer, P.G., Fox, H.M. and Vernet, A.T. (1982) The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney International, 21, 730-738. doi:10.1038/ki.1982.90
|
[11]
|
Kooy, A., de Jager, J., Lehert, P., Bets, D., Wulffelé, M.G., Donker, A.J.M. and Stehouwer, C.D.A. (2009) Long-term effects of metformin on metabolism and micro-vascular and macrovascular disease in patients with Type 2 diabetes mellitus. Archives of Internal Medicine, 169, 616-625. doi:10.1001/archinternmed.2009.20
|
[12]
|
Nosadini, R. and Tonolo, G. (2004) Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy. Journal of the American Society of Nephrology, 15, S1-S5.
doi:10.1097/01.ASN.0000093372.84929.BA
|
[13]
|
Nathan, D.M., Kuenen, J., Borg, R., Zhengtt, Schoenfeld, D. and Heive, R.J.(2008) Translatingthe A1C assay into estimated average glucose values. Diabetes Care, 31, 1473-1478. doi:10.2337/dc08-0545
|
[14]
|
Mandal, A.K., Hiebert, L.M. and Khamis, H. (2011) dGlucose is linked to renal function changes in diabetes. Diabetes Research and Clinical Practice, 91, 190-194.
doi:10.1016/j.diabres.2010.11.013
|
[15]
|
Palumbo, P.J. (2004) The case for insulin treatment early in type 2 diabetes. Cleveland Clinic Journal of Medicine, 71, 385-405. doi:10.3949/ccjm.71.5.385
|
[16]
|
Holman, R.R., Paul, S.K., Bethel, M.A., Mathews, D.R. and Neil, H.A. (2008) 10 year follow up of intensive glucose control in type 2 diabetes. New England Journal of Medicine, 359, 1577-1589.
doi:10.1056/NEJMoa0806470
|
[17]
|
Heller, S.R., Amiel, S.A., Mansell, P., UK Lispro Study Group (1999) Effect of the fast-acting insulin analog Lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. Diabetes Care, 22, 1607-1611.
doi:10.2337/diacare.22.10.1607
|
[18]
|
Mandal, A.K., Markert, R.J., Saklayen, M.G., Mankus, R.A. and Yokokawa, K. (1994) Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure, Clinical Nephrology, 42, 170-174.
|
[19]
|
Mandal, A.K. and Hiebert, L.M. (2008) Renal protection in diabetes: Is it affected by glucose control or inhibition of renin-angiotensin pathway. Clinical Nephrology, 69, 169-178.
|
[20]
|
Mandal, A.K. (2010) A reversible of acute renal failure associated with renin-angiotensin inhibitor drugs. International Urology and Nephrology, 2, 567-579.
|
[21]
|
Hamaty, M. (2011) Insulin treatment for type 2 diabetes: when to start and which to use. Cleveland Clinic Journal of Medicine, 78, 332-342. doi:10.3949/ccjm.78a.10051
|